Pfizer could have a new vaccine against omicron Covid variant in less than 100 days, CEO Bourla says

Pfizer CEO Albert Bourla sits down with CNBC's Meg Tirrell and the 'Squawk Box' team to discuss how the pharma giant is responding to the worrisome omicron Covid variant.